CRIS Current Research Information System

PALLESCHI, MICHELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.777
NA - Nord America 996
EU - Europa 685
SA - Sud America 116
AF - Africa 54
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.632
Salva come PNG Salva come JPEG
Nazione #
VN - Vietnam 1.059
US - Stati Uniti d'America 962
SG - Singapore 650
CN - Cina 581
IT - Italia 217
HK - Hong Kong 204
NL - Olanda 137
KR - Corea 107
BR - Brasile 88
DE - Germania 78
FR - Francia 58
FI - Finlandia 54
JP - Giappone 43
IN - India 40
CI - Costa d'Avorio 29
SE - Svezia 29
IE - Irlanda 20
GB - Regno Unito 19
ID - Indonesia 18
BD - Bangladesh 17
PH - Filippine 15
RU - Federazione Russa 15
AT - Austria 13
CA - Canada 13
MX - Messico 13
TH - Thailandia 12
SC - Seychelles 10
AR - Argentina 9
CH - Svizzera 9
PL - Polonia 9
EC - Ecuador 8
JO - Giordania 7
BE - Belgio 6
BG - Bulgaria 6
IQ - Iraq 5
CZ - Repubblica Ceca 4
ES - Italia 4
MA - Marocco 4
TW - Taiwan 4
BO - Bolivia 3
CO - Colombia 3
CR - Costa Rica 3
EG - Egitto 3
GH - Ghana 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
DO - Repubblica Dominicana 2
LT - Lituania 2
OM - Oman 2
PK - Pakistan 2
SA - Arabia Saudita 2
TG - Togo 2
UA - Ucraina 2
UZ - Uzbekistan 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CL - Cile 1
ET - Etiopia 1
IL - Israele 1
JM - Giamaica 1
LB - Libano 1
LV - Lettonia 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
SI - Slovenia 1
TR - Turchia 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
ZA - Sudafrica 1
Totale 4.632
Salva come PNG Salva come JPEG
Città #
Singapore 490
Ho Chi Minh City 306
Hanoi 272
Hefei 249
San Jose 194
Hong Kong 192
Ashburn 135
Santa Clara 111
Seoul 101
Amsterdam 94
Dallas 84
Bologna 62
Council Bluffs 46
Beijing 45
Boardman 37
Los Angeles 37
Tokyo 37
Helsinki 36
Da Nang 35
Lauterbourg 33
Haiphong 30
Abidjan 29
Bengaluru 25
Ha Long 23
Chandler 20
Dublin 20
Quận Bình Thạnh 20
Buffalo 19
Thái Nguyên 19
New York 16
Nuremberg 16
Biên Hòa 15
Can Tho 15
Frankfurt am Main 15
Milan 15
Munich 15
Jakarta 14
Chicago 13
Hải Dương 13
Lappeenranta 12
Phủ Lý 11
Bắc Giang 10
Falkenstein 10
Ninh Bình 10
Princeton 10
Bắc Ninh 9
Düsseldorf 9
Redondo Beach 9
Vienna 9
Vinh 9
Vũng Tàu 9
Guangzhou 8
Mexico City 8
Rome 8
Xi'an 8
Amman 7
Monzuno 7
Quận Một 7
Quận Phú Nhuận 7
Quận Sáu 7
Cesena 6
Montreal 6
Quận Bảy 6
Shanghai 6
Sofia 6
Southend 6
Turku 6
Wilmington 6
Bern 5
Brooklyn 5
Brussels 5
Changsha 5
Hangzhou 5
Lấp Vò 5
Modena 5
Nam Định 5
Qingdao 5
Quận Tân Phú 5
Rio de Janeiro 5
São Paulo 5
Thái Bình 5
Turin 5
Warsaw 5
Bạc Liêu 4
Can Giuoc 4
Chengdu 4
Fuzhou 4
Huế 4
Quezon City 4
Quảng Ngãi 4
Ravenna 4
Salt Lake City 4
San Francisco 4
Tam Bình 4
Tongling 4
Yubileyny 4
Zhengzhou 4
Zurich 4
Điện Bàn 4
Accra 3
Totale 3.322
Salva come PNG Salva come JPEG
Nome #
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants 348
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer? 347
HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer 311
The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives 180
Transcriptomic profiling of circulating tumor cells from metastatic breast cancer patients reveals new hints in their biological features and phenotypic heterogeneity 173
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer 164
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy 158
Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis 158
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure 150
Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience 148
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives 143
Case Report: Analysis of Circulating Tumor Cells in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient 137
Case Report: Analysis of Plasma Extracellular Vesicles in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient 129
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment 128
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology 119
Moving beyond parp inhibition: Current state and future perspectives in breast cancer 117
Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyond 116
Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer 112
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 111
Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer: A case report 107
ANTIANGIOGENIC AGENTS ARE INEFFECTIVE TO INCREASE COMPLETE RESPONSE RATE IN MRCC. A META-ANALYSIS 100
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer 85
The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer 84
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial. 79
Are we ready to use TMB in breast cancer clinical practice? 78
Real-world experience and clinical impact of drug-drug interactions in HR+/HER2- advanced breast cancer patients treated with abemaciclib plus endocrine therapy: the AB-ITALY study 75
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab 70
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors 68
Atezolizumab plus Nab-paclitaxel in PD-L1–Positive TNBC—Letter 62
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients 56
Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer? 56
Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives 54
Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients 54
ROLE OF HPV VACCINATION AFTER CARCINOMA IN SITU OF CERVIX UTERI (CIN) IN REAL-WORLD PATIENTS 47
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future Directions 45
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) 44
Body mass index (BMI) and benefit from adjuvant chemotherapy in breast cancer: is it enough? 39
Germline BRCA-mutated metastatic breast cancer with positive hormone receptor 38
Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study 36
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study 32
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET 28
Survey on cancer patients’ attitudes towards AI and data protection: A cross-sectional study from an Italian cancer center 28
Precision medicine: PI3K targeting in advanced breast cancer 24
Corrigendum to “Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives” [Crit. Rev. Oncol./Hematol. 181 (2023) 103900] (Critical Reviews in Oncology / Hematology (2023) 181, (S1040842822003249), (10.1016/j.critrevonc.2022.103900)) 24
Can cyclin-dependent kinase 4/6 inhibitors convert inoperable breast cancer relapse to operability? A case report 22
Ribociclib and endocrine therapy in breast cancer 20
The promise of liquid biopsy in cancer: A clinical perspective 16
Eribulin in brain metastases of breast cancer: Outcomes of the EBRAIM prospective observational trial 10
Totale 4.730
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.619
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202257 0 0 0 4 4 0 3 2 0 9 24 11
2022/2023128 5 11 5 16 7 13 2 8 33 4 9 15
2023/2024143 1 6 1 5 2 7 9 6 66 17 11 12
2024/2025976 35 119 77 68 156 58 40 31 7 89 73 223
2025/20263.426 712 453 424 281 253 69 348 157 535 194 0 0
Totale 4.730